SAKK 16/14: Anti-PD-L1 antibody durvalumab (MEDI4736) in addition to neoadjuvant chemotherapy in patients with stage IIIA(N2) non-small cell lung cancer (NSCLC)—A multicenter single-arm phase II trial.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.tps8573 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. TPS8573-TPS8573 ◽

Author(s):

Sacha Rothschild ◽

Alfred Zippelius ◽

Spasenija Savic ◽

Michel Gonzalez ◽

Walter Weder ◽

...

Keyword(s):

Lung Cancer ◽

Neoadjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Download Full-text

129TiP: SAKK 16/14 – anti-PD-L1 antibody durvalumab (MEDI4736) in addition to neoadjuvant chemotherapy in patients with stage IIIA (N2) non-small cell lung cancer (NSCLC). A multicenter single-arm phase II trial

Journal of Thoracic Oncology ◽

10.1016/s1556-0864(16)30242-8 ◽

2016 ◽

Vol 11 (4) ◽

pp. S112 ◽

Author(s):

S.I. Rothschild ◽

A. Zippelius ◽

S. Savic Prince ◽

M. Gonzalez ◽

W. Weder ◽

...

Keyword(s):

Lung Cancer ◽

Neoadjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Download Full-text

1237MO SAKK 16/14: Anti-PD-L1 antibody durvalumab in addition to neoadjuvant chemotherapy in patients with stage IIIA (N2) non-small cell lung cancer (NSCLC) – A multicenter single-arm phase II trial

Annals of Oncology ◽

10.1016/j.annonc.2020.08.110 ◽

2020 ◽

Vol 31 ◽

pp. S803-S804

Author(s):

S.I. Rothschild ◽

A. Zippelius ◽

E.I. Eboulet ◽

S. Savic Prince ◽

D. Betticher ◽

...

Keyword(s):

Lung Cancer ◽

Neoadjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Download Full-text

126TiP SAKK 16/14: Anti-PD-L1 antibody durvalumab (MEDI4736) in addition to neoadjuvant chemotherapy in patients with stage IIIA(N2) non-small cell lung cancer (NSCLC): A multicenter single-arm phase II trial

Journal of Thoracic Oncology ◽

10.1016/s1556-0864(18)30399-x ◽

2018 ◽

Vol 13 (4) ◽

pp. S70 ◽

Author(s):

S.I. Rothschild ◽

A. Zippelius ◽

S. Savic Prince ◽

M. Gonzalez ◽

W. Weder ◽

...

Keyword(s):

Lung Cancer ◽

Neoadjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Download Full-text

SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small Cell Lung Cancer — A Multicentre Single-Arm Phase II Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3759708 ◽

2021 ◽

Author(s):

Sacha I. Rothschild ◽

Alfred Zippelius ◽

Eric I. Eboulet ◽

Spasenija Savic Prince ◽

Daniel Betticher ◽

...

Keyword(s):

Lung Cancer ◽

Neoadjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Download Full-text

SAKK 16/14: Anti-PD-L1 antibody durvalumab (MEDI4736) in addition to neoadjuvant chemotherapy in patients with stage IIIA(N2) non-small cell lung cancer (NSCLC)—A multicenter single-arm phase II trial.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.tps8584 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. TPS8584-TPS8584

Author(s):

Sacha Rothschild ◽

Alfred Zippelius ◽

Spasenija Savic ◽

Michel Gonzalez ◽

Walter Weder ◽

...

Keyword(s):

Lung Cancer ◽

Neoadjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Download Full-text

Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial

The Lancet Oncology ◽

10.1016/s1470-2045(09)70172-x ◽

2009 ◽

Vol 10 (8) ◽

pp. 785-793 ◽

Author(s):

Roger Stupp ◽

Michael Mayer ◽

Roger Kann ◽

Walter Weder ◽

Abderahim Zouhair ◽

...

Keyword(s):

Lung Cancer ◽

Neoadjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Multicentre Phase

Download Full-text

Phase II Trial of Sequential Chemotherapy Followed by Chemoradiation, Surgery, and Postoperative Chemotherapy for the Treatment of Stage IIIA/IIIB Non-Small-Cell Lung Cancer

Clinical Lung Cancer ◽

10.3816/clc.2006.n.040 ◽

2006 ◽

Vol 8 (2) ◽

pp. 122-129 ◽

Author(s):

Prudence Lam ◽

Stuart Berman ◽

Robert Thurer ◽

Simon Ashiku ◽

Malcolm DeCamp ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Postoperative Chemotherapy ◽

Small Cell Lung ◽

Sequential Chemotherapy

Download Full-text

Docetaxel and cisplatin as induction chemotherapy in stage IIIA N2 non-small cell lung cancer (NSCLC): An EORTC phase II trial (08984)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.7166 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7166-7166 ◽

Author(s):

C. Manegold ◽

B. Biesma ◽

H. Smit ◽

J. Van Meerbeeck ◽

C. Debruyne ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Download Full-text

P-203 SLCG 9901: phase II trial with cisplatin (cis), gemcitabine (gem) and docetaxel (doc) as neoadjuvant treatment in stage IIIA N2 and T4N0-1 non-small cell lung cancer (NSCLC) patients

Lung Cancer ◽

10.1016/s0169-5002(03)92172-6 ◽

2003 ◽

Vol 41 ◽

pp. S142

Author(s):

Pilar Garrido ◽

Ramón Barceló ◽

Angel Artal ◽

Josefa Terrasa ◽

Bartomeu Massuti ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Neoadjuvant Treatment ◽

Small Cell Lung ◽

Download Full-text

Neoadjuvant chemotherapy with navelbine (NVB) plus clsplatin (C) in stage IIIB in non-small cell lung cancer (NSCLC): A phase II trial

European Journal of Cancer ◽

10.1016/s0959-8049(97)86000-5 ◽

1997 ◽

Vol 33 ◽

pp. S241

Author(s):

S. Cigolari ◽

C. Curio ◽

M. Massimo ◽

R. Sessa ◽

M. Vasta ◽

...

Keyword(s):

Lung Cancer ◽

Neoadjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung

Download Full-text